兰氧化和慢性病 矿物和骨疾病:一只老鼠模型
Chao Gu1, Ting Zhang2, Yuan Gao2
1Department of Pharmacy, Ordos City Hospital, Dongsheng District, Ordos City, 017000, Inner Mongolia Autonomous Region, China.
Current vascular pharmacology
|November 14, 2023
概括
兰氧化物有效地治疗宫外矿化和急性损伤大鼠的异常骨. 它通过向NF-κB和RANKL/OPG通路来抑制血管化和纤维化.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 急性损伤 (AKI) 通常导致子宫外矿化和异常的骨发育.
- 软组织化和血管异常是AKI的重要并发症.
- 了解这些并发症背后的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究氧化 (LH) 对 AKI 的老鼠软组织和异常骨外宫矿物化的药理作用.
- 阐明LH影响这些病理过程的分子机制.
主要方法:
- 威斯塔尔老鼠接受了5/6的切除术以诱导AKI.
- 通过口腔输液以不同的剂量 (0.4,0.2,0.1g/kg) 给药LH.
- 分析了血清生物化学指数,病理变化 (通过特定染色),以及蛋白质/基因表达 (西布洛特,qPCR,免疫组织化学).
主要成果:
- LH显著降低了血清酸盐水平和胸前大动脉化.
- 纤维化得到改善,核因子kappa-B (NF-κB) 的核入口减少.
- 骨质标记物的表达减少,而光滑肌肉蛋白22α (SM22α) 增加;股骨RANKL/OPG比率被调节.
结论:
- 兰氧化物有效地抑制了AKI大鼠的血管化和骨异常.
- 这些效应是通过抑制NF-κB和RANKL/OPG信号通路进行介导的.
- 在治疗与AKI相关的并发症方面,LH显示出治疗潜力.
更多相关视频
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
2.0K
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.2K
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
11
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
11
Chronic Kidney Disease I: Introduction
17
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
